SS Innovations InternationalSSII -4.06%39 Cash Ratio is 0.61 as of Mar. 2026, which is 190% above its 10-year median of 0.21. GuruFocus rates SSII with a GF Score™ of 39/100 and a GF Value™ of $18.63 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 843 Medical Devices & Instruments companies, SS Innovations International ranks worse than 63.35% on this metric.
SS Innovations International has a Cash Ratio of 0.61. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for SS Innovations International's Cash Ratio or its related term are showing as below:
SSII'
s Cash Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.21 Max: 3.92
Current: 0.61
During the past 10 years, SS Innovations International's highest Cash Ratio was 3.92. The lowest was 0.01. And the median was 0.21.
SSII's Cash Ratio is ranked worse than 63.35% of 843
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs SSII: 0.61
SS Innovations International (NAS:SSII) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
SS Innovations International Cash Ratio Related Terms
SS Innovations International Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SS Innovations International's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Cash Ratio distribution charts can be found below:
* The bar in red indicates where SS Innovations International's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International (SSII) has a Cash Ratio of 0.61 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on SS Innovations International and its competitors. This is 190% above median its historical median of 0.21. Over the past decade, SS Innovations International's Cash Ratio has ranged from 0.01 to 3.92. According to the industry distribution chart, SS Innovations International ranks #534 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 63.3%.
Is SS Innovations International's Cash Ratio too high?
SS Innovations International's current Cash Ratio of 0.61 is 190% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 3.92. The Medical Devices & Instruments industry median Cash Ratio is 0.97. SS Innovations International's value of 0.61 is 37.1% below this industry median. Based on the distribution chart, SS Innovations International ranks #534 out of 843 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SS Innovations International has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's Cash Ratio compare to BVS and TCMD?
According to the Medical Devices & Instruments industry distribution chart, SS Innovations International ranks #534 out of 843 companies for Cash Ratio. This places SS Innovations International in the lower half of its industry. The industry median Cash Ratio is 0.97. SS Innovations International's value of 0.61 is 37.1% below this benchmark. Historically, SS Innovations International's own Cash Ratio has ranged from 0.01 to 3.92 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.97, SS Innovations International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 843 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SS Innovations International's current Cash Ratio of 0.61 is 37.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on SS Innovations International and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SS Innovations International's current Cash Ratio is 0.61, which is 190% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.63, compared to a current price of $3.79 — trading 79.7% below its estimated fair value. The current Cash Ratio is 0.61, which is 190% above median its 10-year median of 0.21 and 37.1% below the Medical Devices & Instruments industry median of 0.97. SS Innovations International's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For SS Innovations International (SSII), the current Cash Ratio is 0.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.79 is trading 79.7% below its estimated GF Value™ of $18.63.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
Cash Ratio: 0.61 (190% above median its 10-year median of 0.21)
GF Value™: $18.63 vs. price of $3.79 (79.7% below fair value)
Industry Position: 37.1% below the Medical Devices & Instruments median (#534 of 843)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
39GF Score
Get the complete analysis for SSII
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
